Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1989-05-02
1991-06-04
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
423249, 534 10, A61K 4300, C01G 4700
Patent
active
050212354
ABSTRACT:
The process of the present invention includes preparing a first aqueous solution of rhenium in the form of radioactive perrhenate, wherein the concentration of rhenium in said solution is within the range of about 5.times.10.sup.-6 M to about 2.times.10.sup.-3 M, and then reducing and complexing the radioactive perrhenate by mixing a second solution or lyophilized solid with the first solution. The second solution or lyophilized solid comprises a ligand which complexes with the radioactive perrhenate and a reductant wherein the reductant is present in the second solution at a concentration in the range of about 0.005M to about 0.020M and the ligand is present in the second solution at a concentration in the range of about 0.01M and about 0.15M. The pH of the resultant solution is within the range of about 1.5 to about 5.5.
REFERENCES:
patent: 3192011 (1963-08-01), Cooper
patent: 3983227 (1976-09-01), Tofe et al.
patent: 4652440 (1987-03-01), Paik et al.
patent: 4778672 (1988-10-01), Deutsch et al.
patent: 4925925 (1990-05-01), Deutsch
Mathieu et al., Int. J. Appl. Radiat. Isot. 30: 25-27 (1979).
Eisenhut, Int. J. Appl. Radiat. Isot. 33: 99-103 (1982).
Weininger et al., Nucl. Med. 23: 81-82 (1984).
Ketring, Nucl. Med. Biol. 14: 223-232 (1987).
Maxon et al., Radiology 166: 501-507 (1988).
Mallinckrodt Inc.
Maples John S.
LandOfFree
Preparation of rhenium phosphonate therapeutic agents for bone c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of rhenium phosphonate therapeutic agents for bone c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of rhenium phosphonate therapeutic agents for bone c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1025292